H
Helaina
Using yeast, Helaina’s lab nurtures a fermentation process that results in a unique microflora that can express milk
About Helaina
Helaina is a pioneering startup operating in the health and wellness sector, specifically focusing on advanced nutrition. The company's unique selling proposition is its technology platform that replicates functional proteins found in the human body, making them available as new nutrients. This innovative approach to nutrition is aimed at enhancing vitality and overall health.
Helaina's primary product is Effera™, a replicated version of Human Lactoferrin, a protein naturally present in the human body. This protein plays a crucial role in maintaining gut health, optimizing iron utilization, and supporting immune health. By making this protein accessible as a dietary supplement, Helaina is setting a new standard for nutrition.
The company's target market includes health-conscious consumers seeking science-backed, superior quality nutritional supplements. Helaina's business model revolves around the production and sale of these bioactive proteins, which are dietary supplements that go beyond meeting basic nutritional needs and are known to improve health status.
Helaina's team comprises experts in food science, nutrition, and engineering, working together to bring novel food ingredients to the world. The company's innovative approach and commitment to quality have positioned it as a promising player in the health and wellness industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- New York City, United States
- Employees
- 51
- Open positions
- 3
- Dealroom signal
- 66.2/100
- Sub-industry
- Innovative Food
- Sector
- Food, Biotechnology, Synthetic Biology, Alternative Protein, Sustainable Development Goals, Dairy Substitute, Fermentation, Climate Tech, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2024 | $45M | $180M | Tom Williams · Relish Works · Spark Capital · Primary Venture Partners | ↗ |
| SERIES AOther financing | Nov 2021 | $20M | $80M | Plum Alley · Barrel Ventures · Siam Capital · Primary Venture Partners | ↗ |
Growth signals
Latest recorded traffic for Helaina is 3K monthly website visits, up 50% over the last three months. Helaina's team declined 1.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Tom Williams
Scott Belsky
Series A11 investors entered at this stage
Siam Capital
Spark Capital
Plum Alley
Barrel Ventures
Primary Venture Partners- MRMatt Rutler
- GUGabrielle Union
Avidity Partners
Relish Works
Ingeborg Investments
CF Private Equity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Helaina on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Helaina’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.